Sanofi India will commercially launch the first Indian-manufactured re-usable insulin pen, AllStar, in India, in October 2012. Developed especially for patients in emerging markets, AllStar is meant for insulinized patients using Sanofi's ...
Tags: Insulin Pen, emerging markets, Sanofi's insulin portfolio
ViaCyte has received a $10.1m strategic partnership award from the California Institute for Regenerative Medicine (CIRM) to develop VC-01, which is a regenerative medicine, consisting of pancreatic beta cell progenitors in a durable ...
Tags: ViaCyte, Diabetes Therapy Development, CIRM
The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...
Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban
INJEX Pharma and American Healthcare Products have signed an exclusive distribution agreement to market needle-free syringe Injex 30 in the west coast states of US. According to the agreement, American Healthcare Products will distribute ...
Tags: INJEX Pharma, American Healthcare Products, syringe Injex 30
Ranbaxy Pharmaceuticals,a wholly owned subsidiary of Ranbaxy Laboratories(RLL),has launched authorized generic pioglitazone hydrochloride tablets in the US market under an agreement with Takeda Pharmaceuticals US. Pioglitazone ...
Tags: Ranbaxy Pharmaceuticals, Ranbaxy Laboratories, Takeda Pharmaceuticals
Watson Pharmaceuticals has introduced Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets, a generic equivalent to Actos. The company began the shipment of the product after winning the final FDA approval. Actos is a prescription ...
Tags: Generic Version, Actos, blood sugar
Pfizer has granted exclusive development and marketing rights to ChemRar group company SatRx for their DPP(1)-IVi compound, PF-00734200 for type 2 diabetes (T2D). T2D is one of the most burdensome chronic non-communicable diseases, which ...
Tags: Satrx Exclusive License, epidemic proportions, R&D portfolio
Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Irbesartan tablets. Irbesartan, a generic version of Aprovel (Irbesartan) by Sanofi Pharma Bristol-Myers Squibb SNC, is indicated to treat essential ...
Tags: Irbesartan Tablets, antihypertensive medicinal product regimen
Royer Biomedical(RBI)wins FDA approval to progress human testing of AppliGel-G(Gentamicin)in management of diabetic foot ulcers(DFU). The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has ...
Antigua reported that copper dealers will not get the month end green light they were hoping for to resume trading. This as government announced a further extension of the ban on the trading of copper, which had been slated to cease on ...
Tags: Antigua, Copper Trade Ban, copper, resume trading
Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India. Linagliptin, which is approved in the US, the European Union, Japan and ...
Tags: Diabetes Drug, product of Boehringer, diabetes epidemic
The South East Health Technologies Alliance (SEHTA) has launched a UK Healthcare Innovation Hub, which will act as a meeting point for entrepreneurs, academics, researchers and policymakers to develop new and innovative healthcare concepts. ...
Tags: Healthcare Innovation, eco-independent living, elderly people
SportsQuest has announced that its wholly owned subsidiary, Maize Pluss, has signed a contract to distribute organic stevia, an USDA FDA approved organic sweetener. SportsQuest CEO Jeff Burns said that the company is building a very ...
Tags: SportsQuest, Distribution Contract
To increase its capabilities for medical device manufacturing, custom injection molder Plastikos Inc. is in the process of adding a third press for its Class 10,000 clean room at its headquarters plant in Erie. "There is no firm date by ...
The Scottish Medicines Consortium (SMC) has approved the use of Alcon's Nevanac in patients suffering from diabetes to minimize the possibility of postoperative macular oedema (MO) coupled with cataract surgery. The approval allows the ...
Tags: The Scottish Medicines Consortium, diabetic cataract patients, Medicine